Angiodynamics (ANGO) Return on Sales (2016 - 2025)
Historic Return on Sales for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 0.08%.
- Angiodynamics' Return on Sales rose 700.0% to 0.08% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.09%, marking a year-over-year increase of 6900.0%. This contributed to the annual value of 0.12% for FY2025, which is 4900.0% up from last year.
- Latest data reveals that Angiodynamics reported Return on Sales of 0.08% as of Q4 2025, which was up 700.0% from 0.14% recorded in Q3 2025.
- Angiodynamics' 5-year Return on Sales high stood at 0.58% for Q3 2023, and its period low was 2.5% during Q1 2024.
- In the last 5 years, Angiodynamics' Return on Sales had a median value of 0.11% in 2021 and averaged 0.22%.
- As far as peak fluctuations go, Angiodynamics' Return on Sales plummeted by -23800bps in 2024, and later skyrocketed by 24400bps in 2025.
- Quarter analysis of 5 years shows Angiodynamics' Return on Sales stood at 0.11% in 2021, then rose by 7bps to 0.1% in 2022, then crashed by -270bps to 0.37% in 2023, then soared by 60bps to 0.15% in 2024, then soared by 46bps to 0.08% in 2025.
- Its last three reported values are 0.08% in Q4 2025, 0.14% for Q3 2025, and 0.08% during Q2 2025.